Overall, the data presented in this study further illustrate a role for Sema4A-oligodendrocyte interaction in the etiology of demyelinating diseases by showing direct, adverse in vivo effects of the protein on oligodendrocytes and myelin homeostasis. This evidence concerns the gene SEMA4A and demyelinating disease.